Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030

被引:1
|
作者
V. Kim, Thanh [1 ,2 ]
Pham, Trang N. D. [3 ,4 ]
Le, Duc H. [1 ]
Dao, Diem V. B. [4 ]
Phan, Loc T. B. [4 ]
Le, Anh [4 ]
Trang, Amy [4 ]
Tang, Hong K. [1 ]
Liu, Jason J. [2 ,5 ,7 ]
Dao, Doan Y. [4 ,6 ,8 ]
机构
[1] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam
[2] Natl Yang Ming Chiao Tung Univ, Coll Med, Int Hlth Program, Taipei, Taiwan
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[4] Vietnam Viral Hepatitis Alliance, Reston, VA USA
[5] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan
[6] Johns Hopkins Univ, Ctr Excellence Liver Dis Viet Nam, Sch Med, Baltimore, MD USA
[7] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Med Bldg II,155,Sect 2,Linong St, Taipei, Taiwan
[8] Johns Hopkins Univ, Sch Med, Ross Res Bldg,Room 310,720 Rutland Ave, Baltimore, MD 21205 USA
关键词
Hepatitis B virus; Vaccination; Elimination; Survey; Adult; Viet Nam; Lower-middle-income country; INFECTION; VIRUS;
D O I
10.1016/j.vaccine.2022.12.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Gaps in adult hepatitis B vaccination were undefined in Vietnam, a lower-middle-income country. To address these gaps, this study defined hepatitis B vaccine coverage in adults and its associated factors in Ho Chi Minh City (HCMC), Viet Nam. We also proposed interventional strategies, prioritizing gap identification to facilitate hepatitis B elimination by 2030 and beyond.Method: During 2019-2020, a multi-stage cluster serosurvey with probability proportional to size was conducted to representatively invite 20,000 adults (18 years or older) throughout HCMC for hepatitis B screening (HBsAg, anti-HBs, and anti-HBc). Serologic results defined two dependent variables: vaccine -induced immunity (i.e., isolated anti-HBs) and susceptibility (i.e., HBV naive). Associations of dependent variables with surveyed demographics, socioeconomic statuses, behaviors, and medical history at risk for hepatitis B were evaluated using weighted Poisson regression.Results: The prevalence was 18.5% (95%CI, 17.3-20.0%) for vaccine-induced immunity and 37.7% (35.6-39.8%) for susceptibility. Even though analyses in the general population revealed a falling trend in vaccine-induced immunity prevalence from younger to older age groups, sensitivity analyses in the non-infected population (i.e., those who were both negative for HBsAg and anti-HBc) showed that younger age groups, especially those aged 30 to 50 years, had the lowest prevalence. Social inequalities existed in different ethnicities, residence areas, education levels, house ownership, and health insurance statuses. There was no significant association between vaccine-induced immunity or susceptibility and risky behaviors and medical histories.Conclusion: This study depicts a significant unmet need for hepatitis B vaccination in the general adult population in HCMC, Viet Nam. Indeed, the lack of vaccination was unevenly distributed regarding age groups, geographical areas, and socioeconomic statuses, which reveals profound social disparities. Therefore, to achieve hepatitis B elimination goals, besides the current recommendations for infants and risk-based strategies, hepatitis B vaccination should be recommended for the broader population.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页码:976 / 988
页数:13
相关论文
共 50 条
  • [31] Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease
    Yue, Xin
    Black, Carla L.
    O'Halloran, Alissa
    Lu, Peng-Jun
    Williams, Walter W.
    Nelson, Noele P.
    VACCINE, 2018, 36 (09) : 1183 - 1189
  • [32] Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China
    Chen, Shu
    Mao, Wenhui
    Guo, Lei
    Zhang, Jiahui
    Tang, Shenglan
    BMJ GLOBAL HEALTH, 2020, 5 (06):
  • [33] Hepatitis A screening and vaccination coverage among adults with chronic hepatitis B infection
    Peverelle, M.
    Mills, C.
    Testro, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 63 - 64
  • [34] Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness
    Partida, Diana
    Powell, Jesse
    Gonzalez, Daniel
    Khalili, Mandana
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):
  • [35] Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination
    Zhu, Chang-Lin
    Liu, Ping
    Chen, Taoyang
    Ni, Zhengping
    Lu, Ling-Ling
    Huang, Fei
    Lu, Jianhua
    Sun, Zongtang
    Qu, Chunfeng
    VACCINE, 2011, 29 (44) : 7835 - 7841
  • [36] Hepatitis B Virus Infection and the Progress toward its Elimination
    Hsu, Hong-Yuan
    Chang, Mei-Hwei
    JOURNAL OF PEDIATRICS, 2019, 205 : 12 - 20
  • [37] The response of hepatitis B vaccination on seronegative adults with different vaccination schedules
    Yao, Jun
    Li, Jing
    Chen, Yongdi
    Shan, Huan
    Dai, Xue-wei
    Yang, Lin-na
    Jiang, Zheng-gang
    Ren, Jing-jing
    Xu, Kai-jin
    Ruan, Bing
    Yang, Shi-gui
    Wang, Bing
    Xie, Tian-sheng
    Li, Qian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (05) : 1102 - 1107
  • [38] Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021
    Khetsuriani, Nino
    Gamkrelidze, Amiran
    Shadaker, Shaun
    Tsereteli, Maia
    Alkhazashvili, Maia
    Chitadze, Nazibrola
    Tskhomelidze, Irina
    Gvinjilia, Lia
    Averhoff, Francisco
    Cloherty, Gavin
    An, Qian
    Chakhunashvili, Giorgi
    Drobeniuc, Jan
    Imnadze, Paata
    Zakhashvili, Khatuna
    Armstrong, Paige A.
    EUROSURVEILLANCE, 2023, 28 (30) : 12 - 23
  • [39] Genetic diversity and nucleoside analogues resistance mutations of hepatitis B virus in Russian Federation and Viet Nam
    Elpaeva, E. A.
    Komissarov, A. B.
    Poretskova, E. A.
    Dudanova, O. P.
    Tuyen, D. T.
    Pisareva, M. M.
    Esaulenko, E. V.
    Grudinin, M. P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S11 - S11
  • [40] TOWARD UNIVERSAL VACCINATION AGAINST HEPATITIS-B VIRUS
    HOOFNAGLE, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (19): : 1333 - 1334